According to AI News, on December 23rd, BeiGene announced that the stock code of its American Depositary Shares traded on NASDAQ will be changed from "BGNE" to "ONC", effective from January 2, 2025. This change aims to demonstrate the company's firm commitment to providing innovative cancer drugs on a global scale. The stock code and securities abbreviation of the company on the Shanghai Stock Exchange and the Hong Kong Stock Exchange remain unchanged. The change of NASDAQ stock code can be implemented without the need to submit it to the company's shareholders' meeting for review. The company will fulfill its information disclosure obligations in a timely manner based on the progress of relevant matters.